AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
Log in

NASDAQ:CTMXCytomX Therapeutics News Headlines

$9.07
-0.21 (-2.26 %)
(As of 05/26/2020 02:34 PM ET)
Add
Compare
Today's Range
$8.73
Now: $9.07
$9.47
50-Day Range
$7.51
MA: $10.00
$14.64
52-Week Range
$3.60
Now: $9.07
$15.44
Volume1.54 million shs
Average Volume811,948 shs
Market Capitalization$416.49 million
P/E RatioN/A
Dividend YieldN/A
Beta0.78

Headlines

CytomX Therapeutics (NASDAQ CTMX) News Headlines

Source:
DateHeadline
CytomX Therapeutics to Host Conference Call and Webcast to Review ASCO ASCO20 Virtual Scientific Program PresentationsCytomX Therapeutics to Host Conference Call and Webcast to Review ASCO ASCO20 Virtual Scientific Program Presentations
www.marketwatch.com - May 26 at 12:59 PM
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmIMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 25 at 7:35 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytomX Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2020 - CTMXSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CytomX Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 20, 2020 - CTMX
finance.yahoo.com - May 25 at 7:35 PM
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmINVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 24 at 11:15 PM
CTMX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the FirmCTMX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - May 24 at 1:14 PM
Pomerantz Law Firm Announces the Filing of a Class Action against CytomX Therapeutics Inc. and Certain Officers – CTMXPomerantz Law Firm Announces the Filing of a Class Action against CytomX Therapeutics Inc. and Certain Officers – CTMX
www.benzinga.com - May 24 at 12:15 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CytomX Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - CTMXSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CytomX Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - CTMX
finance.yahoo.com - May 23 at 2:14 PM
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of DOYU, HAFC and CTMXThe Gross Law Firm Announces Class Actions on Behalf of Shareholders of DOYU, HAFC and CTMX
finance.yahoo.com - May 22 at 6:36 PM
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The FirmLEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The Firm
finance.yahoo.com - May 22 at 6:36 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SERV, BIDU and CTMXThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SERV, BIDU and CTMX
finance.yahoo.com - May 22 at 6:36 PM
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of ...SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of ...
www.businesswire.com - May 22 at 1:35 PM
CYTOMX THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CytomX Therapeutics, Inc. and Encourages Investors to ...CYTOMX THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CytomX Therapeutics, Inc. and Encourages Investors to ...
www.businesswire.com - May 22 at 1:35 PM
CYTOMX THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the FirmCYTOMX THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - May 22 at 1:35 PM
CTMX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the FirmCTMX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - May 22 at 1:35 PM
Pomerantz Law Firm Announces the Filing of a Class Action against CytomX Therapeutics Inc. and Certain Officers - CTMXPomerantz Law Firm Announces the Filing of a Class Action against CytomX Therapeutics Inc. and Certain Officers - CTMX
www.marketwatch.com - May 21 at 10:09 PM
Pomerantz Law Firm Announces the Filing of a Class Action against CytomX Therapeutics Inc. and Certain Officers – CTMXPomerantz Law Firm Announces the Filing of a Class Action against CytomX Therapeutics Inc. and Certain Officers – CTMX
finance.yahoo.com - May 21 at 10:09 PM
EQUITY ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Announces Filing of Securities Class Action Lawsuit Against CytomX Therapeutics, Inc. – CTMXEQUITY ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Announces Filing of Securities Class Action Lawsuit Against CytomX Therapeutics, Inc. – CTMX
finance.yahoo.com - May 21 at 10:09 PM
CytomX Therapeutics Inc (NASDAQ:CTMX) Short Interest Down 14.4% in MayCytomX Therapeutics Inc (NASDAQ:CTMX) Short Interest Down 14.4% in May
www.americanbankingnews.com - May 21 at 8:10 PM
SECURITIES FRAUD LAWSUIT FILED: CytomX Therapeutics, Inc. Sued for Securities Fraud; Investors Who Have Lost Money Should Contact Block & Leviton LLPSECURITIES FRAUD LAWSUIT FILED: CytomX Therapeutics, Inc. Sued for Securities Fraud; Investors Who Have Lost Money Should Contact Block & Leviton LLP
finance.yahoo.com - May 21 at 5:09 PM
Is This Innovative Cancer Research Biotech a Buy?Is This Innovative Cancer Research Biotech a Buy?
finance.yahoo.com - May 20 at 11:04 AM
CytomX Therapeutics (NASDAQ:CTMX) Rating Reiterated by NomuraCytomX Therapeutics (NASDAQ:CTMX) Rating Reiterated by Nomura
www.americanbankingnews.com - May 18 at 12:30 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of  CytomX Therapeutics, Inc. - CTMXSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of  CytomX Therapeutics, Inc. - CTMX
finance.yahoo.com - May 15 at 1:17 PM
CytomX down on underwhelming data on Probody candidatesCytomX down on underwhelming data on Probody candidates
seekingalpha.com - May 14 at 8:01 PM
CytomX Therapeutics Inc (NASDAQ:CTMX) CEO Sells $540,000.00 in StockCytomX Therapeutics Inc (NASDAQ:CTMX) CEO Sells $540,000.00 in Stock
www.americanbankingnews.com - May 14 at 6:23 PM
CTMX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of CytomX Therapeutics, Inc. and Encourages Investors to Contact the FirmCTMX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of CytomX Therapeutics, Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - May 14 at 3:00 PM
CytomX Therapeutics (NASDAQ:CTMX) Given New $12.00 Price Target at HC WainwrightCytomX Therapeutics (NASDAQ:CTMX) Given New $12.00 Price Target at HC Wainwright
www.americanbankingnews.com - May 14 at 8:27 AM
CytomX Therapeutics announces presentations at ASCO20 virtual scientific program, Shares down 23%CytomX Therapeutics announces presentations at ASCO20 virtual scientific program, Shares down 23%
seekingalpha.com - May 13 at 6:58 PM
CytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific ProgramCytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program
finance.yahoo.com - May 13 at 6:58 PM
CytomX Therapeutics Inc (NASDAQ:CTMX) Short Interest UpdateCytomX Therapeutics Inc (NASDAQ:CTMX) Short Interest Update
www.americanbankingnews.com - May 11 at 10:10 PM
CytomX Therapeutics Inc (NASDAQ:CTMX) Expected to Announce Quarterly Sales of $17.73 MillionCytomX Therapeutics Inc (NASDAQ:CTMX) Expected to Announce Quarterly Sales of $17.73 Million
www.americanbankingnews.com - May 11 at 5:42 AM
CytomX Therapeutics, Inc. Just Beat Earnings Expectations: Heres What Analysts Think Will Happen NextCytomX Therapeutics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
finance.yahoo.com - May 10 at 5:14 PM
CytomX Therapeutics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextCytomX Therapeutics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
finance.yahoo.com - May 10 at 5:14 PM
Upgrade: Analysts Just Made A Meaningful Increase To Their CytomX Therapeutics, Inc. (NASDAQ:CTMX) ForecastsUpgrade: Analysts Just Made A Meaningful Increase To Their CytomX Therapeutics, Inc. (NASDAQ:CTMX) Forecasts
finance.yahoo.com - May 9 at 4:09 PM
CytomX Therapeutics Inc (NASDAQ:CTMX) Expected to Post Earnings of -$0.34 Per ShareCytomX Therapeutics Inc (NASDAQ:CTMX) Expected to Post Earnings of -$0.34 Per Share
www.americanbankingnews.com - May 9 at 4:41 AM
CytomX Therapeutics (NASDAQ:CTMX) Price Target Increased to $16.00 by Analysts at HC WainwrightCytomX Therapeutics (NASDAQ:CTMX) Price Target Increased to $16.00 by Analysts at HC Wainwright
www.americanbankingnews.com - May 8 at 11:25 PM
Edited Transcript of CTMX earnings conference call or presentation 7-May-20 9:00pm GMTEdited Transcript of CTMX earnings conference call or presentation 7-May-20 9:00pm GMT
finance.yahoo.com - May 8 at 3:56 PM
CytomX Therapeutics, Inc. (CTMX) Q1 2020 Earnings Call TranscriptCytomX Therapeutics, Inc. (CTMX) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 8 at 3:56 PM
CytomX Therapeutics (NASDAQ:CTMX) Receives "Buy" Rating from MizuhoCytomX Therapeutics (NASDAQ:CTMX) Receives "Buy" Rating from Mizuho
www.americanbankingnews.com - May 8 at 6:57 AM
Mizuho Securities Sticks to Their Buy Rating for CytomX Therapeutics IncMizuho Securities Sticks to Their Buy Rating for CytomX Therapeutics Inc
finance.yahoo.com - May 8 at 2:49 AM
All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong BuyAll You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy
finance.yahoo.com - May 7 at 4:48 PM
CytomX Therapeutics Announces First Quarter 2020 Financial Results and Provides Business UpdateCytomX Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - May 7 at 4:48 PM
CytomX Therapeutics to Present at the 2020 Bank of America Securities Health Care ConferenceCytomX Therapeutics to Present at the 2020 Bank of America Securities Health Care Conference
finance.yahoo.com - May 5 at 8:26 AM
CytomX Therapeutics (NASDAQ:CTMX) Receives Buy Rating from MizuhoCytomX Therapeutics (NASDAQ:CTMX) Receives Buy Rating from Mizuho
www.americanbankingnews.com - May 2 at 12:28 AM
CytomX Therapeutics Inc (NASDAQ:CTMX) Receives Average Rating of "Buy" from AnalystsCytomX Therapeutics Inc (NASDAQ:CTMX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - May 1 at 6:01 PM
NetworkNewsBreaks - CytomX Therapeutics Inc. (NASDAQ: CTMX) Featured in Mizuho Securities Research ReportNetworkNewsBreaks - CytomX Therapeutics Inc. (NASDAQ: CTMX) Featured in Mizuho Securities Research Report
www.marketwatch.com - May 1 at 5:59 PM
CytomX Therapeutics (CTMX) Expected to Beat Earnings Estimates: Should You Buy?CytomX Therapeutics (CTMX) Expected to Beat Earnings Estimates: Should You Buy?
www.nasdaq.com - April 30 at 3:53 PM
CytomX Therapeutics Announces Presentations at the 2020 American Society of Clinical Oncology Virtual Scientific ProgramCytomX Therapeutics Announces Presentations at the 2020 American Society of Clinical Oncology Virtual Scientific Program
finance.yahoo.com - April 29 at 4:23 PM
CytomX Therapeutics Appoints Halley E. Gilbert to Board of DirectorsCytomX Therapeutics Appoints Halley E. Gilbert to Board of Directors
finance.yahoo.com - April 28 at 6:06 PM
CytomX Therapeutics to Announce First Quarter 2020 Financial ResultsCytomX Therapeutics to Announce First Quarter 2020 Financial Results
finance.yahoo.com - April 27 at 11:14 AM
Why CytomX Therapeutics (CTMX) Stock Might be a Great PickWhy CytomX Therapeutics (CTMX) Stock Might be a Great Pick
finance.yahoo.com - April 23 at 12:40 PM
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.